1. Wood, M, Vogel, V, Ng, AK, et al. Second malignant neoplasms: assessment and strategies for risk reduction. J Clin Oncol 2012; 30: 3734–3745.
Google Scholar | Crossref | Medline2. Donin, N, Filson, C, Drakaski, A, et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 2016; 122: 3075–3086.
Google Scholar | Crossref | Medline3. Saletta, F, Seng, M, Lau, L. Advances in pediatric cancer treatment. Transl Pediatr 3(2): 156-82.
Google Scholar | Medline4. Ward, E, DeSantis, C, Robbins, A, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014; 64: 83–103.
Google Scholar | Crossref | Medline5. Institute, NC . Childhood Cancer by site incidence, survival and mortality 2019, April, https://seer.cancer.gov/csr/1975_2016/results_merged/sect_28_childhood_cancer.pdf
Google Scholar6. Armstrong, GT, Liu, Q, Yasui, Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the childhood cancer survivor study. J Clin Oncol 2009; 27: 2328–2338.
Google Scholar | Crossref | Medline7. Lee, JS, Dubois, SG, Coccia, PF, et al. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer 2016; 122: 116–123.
Google Scholar | Crossref | Medline8. Siegel, RL, Miller, KD, Jemal, A. Cancer statistics. CA Cancer J Clin 2018; 68: 17–30.
Google Scholar9. Mariotto, AB, Rowland, JH, Yabroff, KR, et al. Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 2009; 18: 1033–1040.
Google Scholar | Crossref | Medline10. Zhang, Y, Goddard, K, Spinelli, JJ, et al. Risk of late mortality and second malignant neoplasms among 5-year survivors of young adult cancer: a report of the childhood, adolescent, and young adult cancer survivors research program. J Cancer Epidemiol 2012; 2012: 103032.
Google Scholar | Crossref | Medline11. Friedman, DL, Whitton, J, Leisenring, W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the childhood cancer survivor study. J Natl Cancer Inst 2010; 102: 1083–1095.
Google Scholar | Crossref | Medline12. Austin, L, Brown, P, Arroyo, VM, et al. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: a population-based assessment. Cancer 2019; 125: 3623–3630.
Google Scholar | Crossref | Medline13. Amy Berrington de Gonzalez, D, Rochelle, E, Curtis, M, et al. The proportion of second cancers attributable to radiotherapy treatment in adults: a prospective cohort study in the US SEER cancer registries. Lancet Oncol 2011; 12: 353–360.
Google Scholar | Crossref | Medline14. De Vathaire, F, Haddy, N, Allodji, RS, et al. Thyroid radiation dose and other risk factors of thyroid carcinoma following childhood cancer. J Clin Endocrinol Metab 2015; 100: 4282–4290.
Google Scholar | Crossref | Medline15. Sun, LM, Lin, CL, Liang, JA, et al. Radiotherapy did not increase thyroid cancer risk among women with breast cancer: a nationwide population-based cohort study. Int J Cancer 2015; 137: 2896–2903.
Google Scholar | Crossref | Medline16. Veiga, LHS, Bhatti, P, Ronckers, CM, et al. Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 2012; 21: 92–101.
Google Scholar | Crossref | Medline17. Chao, C, Bhatia, S, Xu, L, et al. Incidence, risk factors, and mortality associated with second malignant neoplasms among survivors of adolescent and young adult cancer. JAMA Netw Open 2019; 2: e195536.
Google Scholar | Crossref | Medline18. Keegan, THM, Bleyer, A, Rosenberg, AS, et al. Second primary malignant neoplasms and survival in adolescent and young adult cancer survivors. JAMA Oncol 2017; 3: 1554.
Google Scholar | Crossref19. Lau, BJ, Goldfarb, M. Age at primary malignancy determines survival in adolescent and young adults that develop a secondary thyroid cancer. J Adolesc Young Adult Oncol 2016; 5: 201–208.
Google Scholar | Crossref | Medline20. Goldfarb, M . Comparison of secondary and primary thyroid cancer in adolescents and young adults thyroid cancer in AYAs. Cancer 2014; 120: 1155–1161.
Google Scholar | Crossref | Medline21. Trinh, LN, Crawford, AR, Hussein, MH, et al. Deciphering the risk of developing second primary thyroid cancer following a primary malignancy-who is at the greatest risk? Cancers 2021; 13: 1402.
Google Scholar | Crossref22. Nikiforov, UE, Ohori, NP, Hodak, SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011; 11: 3390–3397.
Google Scholar | Crossref23. Cantara, S, Capezzone, M, Marchisotta, S, et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 2010; 95: 1365–1369.
Google Scholar | Crossref | Medline24. Hsiao, SJ, Nikiforov, YE. Molecular approaches to thyroid cancer diagnosis. Endocr Relat Cancer 2014; 21: T301–T313.
Google Scholar | Medline25. Lee, TY, Lee, S, Bae, JS, et al. Distinct clinical manifestations of thyroid cancer after hematopoietic stem cell transplant. Ann Surg Oncol 2019; 26: 3586–3592.
Google Scholar | Crossref | Medline26. Schonfeld, SJ, Morton, LM, González, ABd, et al. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015. Cancer Epidemiol 2020; 64: 101664.
Google Scholar | Crossref | Medline27. Lupi, C, Giannini, R, Ugolini, C, et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 2007; 92: 4085–4090.
Google Scholar | Crossref | Medline28. Ylli, D, Patel, A, Jensen, K, et al. Microfluidic droplet digital PCR is a powerful tool for detection of BRAF and TERT mutations in papillary thyroid carcinomas. Cancers (Basel) 2019; 11: 1916.
Google Scholar | Crossref | Medline29. Bogdanova, TI, Saenko, VA, Hashimoto, Y, et al. Papillary thyroid carcinoma in Ukraine after chernobyl and in Japan after fukushima: different histopathological scenarios. Thyroid 2021; 31: 1322–1334.
Google Scholar | Crossref | Medline30. Ng, AK, Kenney, LB, Gilbert, ES, et al. Secondary malignancies across the age spectrum. Semin Radiat Oncol 2010; 20: 67–78.
Google Scholar | Crossref | Medline31. Nikiforov, Y, Gnepp, DR. Pediatric thyroid cancer after the chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer 1994; 74: 748–766.
Google Scholar | Crossref | Medline32. Nilubol, N, Zhang, L, Kebebew, E. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin. Thyroid 2013; 23: 695–702.
Google Scholar | Crossref | Medline33. Li, CH, Haider, S, Shiah, YJ, et al. Sex differences in cancer driver genes and biomarkers. Cancer Res 2018; 78: 5527–5537.
Google Scholar | Crossref | Medline34. Oliveira, DM, Mirante, T, Mignogna, C, et al. Simultaneous identification of clinically relevant single nucleotide variants, copy number alterations and gene fusions in solid tumors by targeted next-generation sequencing. Oncotarget 2018; 9: 22749–22768.
Google Scholar | Crossref | Medline35. Dong, L, Wang, S, Fu, B, et al. Evaluation of droplet digital PCR and next generation sequencing for characterizing DNA reference material for KRAS mutation detection. Sci Rep 2018; 8: 9650.
Google Scholar | Crossref | Medline36. Jacob, P, Bogdanova, TI, Buglova, E, et al. Thyroid cancer among Ukrainians and Belarusians who were children or adolescents at the time of the Chernobyl accident. J Radiol Prot 2006; 26: 51–67.
Google Scholar | Crossref | Medline37. Demidchik, YE, Saenko, VA, Yamashita, S. Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present. Arq Bras Endocrinol Metabol 2007; 51: 748–762.
Google Scholar | Crossref | Medline38. Cordioli Moraes, L, Cury, AN, Cerutti, JM. Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma. Endocr Relat Cancer 2015; 22: R311–R324.
Google Scholar | Crossref | Medline39. Bogdanova, TI, Saenko, VA, Hirokawa, M, et al. Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine. Endocr J 2017; 64: 977–993.
Google Scholar | Crossref | Medline40. Reiners, C . Radioactivity and thyroid cancer. Hormones 2009; 8: 185–191.
Google Scholar | Crossref | Medline41. Ricarte-Filho, JC, Li, S, Garcia-Rendueles, MER, et al. Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers. J Clin Invest 2013; 123: 4935–4944.
Google Scholar | Crossref | Medline42. Heiden, KB, Williamson, AJ, Doscas, ME, et al. The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression. J Clin Endocrinol Metab 2014; 99: E2178–E2187.
Google Scholar | Crossref | Medline43. Xu, X, Lu, Y, Li, Y, et al. Sonic hedgehog signaling in thyroid cancer. Front Endocrinol 2017; 8: 284.
Google Scholar | Crossref | Medline